Symbols

XRAY

DENTSPLY·NASDAQ

--(--)

XRAY fundamentals

XRAY Q4 2025 Earnings

DENTSPLY (XRAY) released its earnings on Feb 26, 2026: revenue was 961.00M (YoY +6.19%), beat estimates; EPS was 0.27 (YoY +3.85%), missed estimates.

Revenue / YoY

961.00M

+6.19%

EPS / YoY

0.27

+3.85%

Report date

Feb 26, 2026

XRAY Earnings Call Summary for Q4,2025

Revenue Growth: Q4 2025 at $661M (+6.2% YoY), 2026 guidance of $3.5-3.6B reflects operational challenges but sets stage for 2H26 recovery.
Profitability: 2025 Adjusted EPS $1.60, 2026 target $1.40-1.50 with $120M annual savings from restructuring.
Strategic Shifts: Dividend elimination to free $128M/year, $120M annual reinvestment in growth initiatives.
U.S. Focus: Dealer channel expansion, +50% clinical education, and R&D acceleration to drive implants and ortho recovery.
Risks: $30M dealer inventory headwind in 2026, tariff impacts ($15M/Q4), and China BBP uncertainty.

Earnings

EPS

Revenue

Revenue & Expenses

XRAY has released its 2025 Q4 earnings report, with revenue of 961.00M, reflecting a YoY change of 6.19%, and net profit of -145.00M, showing a YoY change of 66.12%. The Sankey diagram below clearly presents XRAY's revenue sources and cost distribution.

Key Indicators

DENTSPLY (XRAY) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

DENTSPLY (XRAY)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

DENTSPLY (XRAY)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

DENTSPLY (XRAY)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown